A nurse is preparing to administer 1 pint of fluid. What is the metric equivalent?

A. By developing evidence-based strategies and educational materials: The Institute for Safe Medication Practices focuses on identifying causes of medication errors and sharing evidence-based recommendations to prevent them. Through alerts, guidelines, and education, it helps healthcare professionals improve medication safety practices.

B. By manufacturing medications: ISMP does not manufacture medications. Its role is centered on safety advocacy, research, and education rather than pharmaceutical production.

C. By providing direct patient care: ISMP does not deliver hands-on patient care. Instead, it supports clinicians and organizations by promoting safer systems and practices related to medication use.

D. By enforcing legal regulations: ISMP is not a regulatory or enforcement body. While its recommendations influence policy and practice, it does not have legal authority to enforce medication safety regulations.

A. Insulin glargine: Insulin glargine is a long-acting basal insulin with no pronounced peak, used to maintain baseline glucose control. It is not intended for rapid correction of postprandial glucose elevations or administration immediately before meals.

B. NPH insulin: NPH insulin is an intermediate-acting insulin with an onset of 1 to 2 hours and a pronounced peak several hours later. Its timing does not align with immediate postprandial glucose rises.

C. Insulin lispro: Insulin lispro is a rapid-acting insulin with an onset of approximately 10 to 15 minutes, making it ideal for administration shortly before meals. It effectively controls postprandial glucose spikes by matching insulin action with carbohydrate absorption.

D. Regular insulin: Regular insulin has an onset of 30 to 60 minutes and is typically administered 30 minutes before meals. It does not act quickly enough to optimally manage glucose levels when given 15 minutes prior to eating.